DEtection of Cellular Inflammation with FERumoxytol in the HEART
Phase of Trial: Phase II/III
Latest Information Update: 06 May 2017
Price : $35 *
At a glance
- Drugs Ferumoxytol (Primary)
- Indications Heart transplant rejection; Myocarditis; Sarcoidosis
- Focus Diagnostic use
- Acronyms DECIFER-HEART
- 02 May 2017 Status changed from recruiting to completed.
- 16 Oct 2015 Accrual to date is 58%, according to the United Kingdom Clinical Research Network record.
- 06 Sep 2015 Accrual to date is 51%, according to the United Kingdom Clinical Research Network record.